SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000899140-22-000504
Filing Date
2022-05-05
Accepted
2022-05-05 11:00:01
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A INFORMATION a050522a.htm DFAN14A 14339
2 PRESS RELEASE, DATED MAY 5, 2022 a050522b.htm EX-99.1 25545
  Complete submission text file 0000899140-22-000504.txt   41100
Mailing Address
Business Address
KAYNE RICHARD A (Filed by) CIK: 0000884413 (see all company filings)

Type: DFAN14A

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Subject) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-39503 | Film No.: 22894816
SIC: 2836 Biological Products, (No Diagnostic Substances)